Ascendiant Capital Initiates Cytori Therapeutics With Buy

By: via Benzinga
Ascendiant Capital initiated coverage on Cytori Therapeutics Inc (NASDAQ: CYTX) with a Buy rating. The target price for Cytori ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.